Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:

Grant Amount: $160K FOR ONE YEAR
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Aug 25, 2010
Sponsor's: Sep 01, 2010

Subject Areas: Intellectual Property, Commercialization, Drug Development, Health Research, Imaging, Cancer, Aging, Technology Transfer

The goal of the Proof of Principle Program is to facilitate and improve the transfer of knowledge and technology resulting from academic health research for the benefit of Canadians. Many of the inventions and discoveries (products/tools/services) arising through academic research are at a stage beyond discovery-driven research and yet are often of uncertain commercial utility or insufficiently developed to be of interest to relevant receptor companies and potential investors. Such intellectual property may never be licensed or commercialized, or take years to do so, without additional targeted research, market research, investment and business development activities. These activities are of paramount importance, because they serve to validate, better define and add value to the intellectual property but they require resources that typically cannot be obtained through the traditional funding mechanisms. CIHR's Proof of Principle Program aims at filling part of this funding gap.

The stage of research that best fits the POP Phase I is one where the IP has been subjected to an initial technology assessment; and where one has already worked out what the novel invention is, what is needed to be protected (or is protected), what will be the product/process/service, and what will be commercialized. Usually applicants have significant data and are planning or expanding critical and confirmatory proof of principle tests in the proposal. Applications focused solely on prototype construction will not be considered. It is expected that the applications put forth be for proof of principle research on intellectual property that has been subjected to an initial technology assessment and selected for its significant commercial potential. To complete your Application, follow the instructions identified in the Proof of Principle Grants - ResearchNet "Application" Phase Instructions. For POP Phase I applications, CIHR has announced priority areas for funding : cancer research in early detection, imaging and/or translational therapeutics; drug development; and mobility in aging innovations.

Application Details:

Proof of Principle Phase I (POP-I) Grants will fund proof of principle research projects of up to 12 months duration designed to advance discoveries/inventions towards commercializable technologies, with a view to attract new investment and create new science-based businesses. Research projects across all four pillars of CIHR are eligible for this program. Note that the end product is not required to generate revenue, but there must be a demonstrated market and opportunity for your product.

New for 2010: Elimination of LOI stage of review. Applicants are reminded to carefully follow the guidelines and to contact the CIHR representatives listed below to clarify any potential eligibility issues or questions before submitting their application. The IP must have been subjected to an initial technology assessment and selected for its significant commercial potential. A Canadian-based party must own at least 50% of the IP proposed or have an inter-institutional agreement in place detailing how existing and new IP will be handled by Canadian stakeholders. Your Application will be submitted using ResearchNet. Scan and upload the signed signature pages including the routing slip in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application. 2.Full Applications must be supported and signed by the Director of the Technology Transfer Office (or equivalent) of an eligible institution. They are to sign in "block 2" of the Institution Signatures page.


NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline.
Western Contacts: Pocock,Katy
Russelo,Theresa M

Sponsor Contacts:

160 Elgin Street, 9th Floor
Address Locator 4809A
OTTAWA, Ontario, Canada
613 941-2672